Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns...

Area of Science:

• Genetics
• Cancer Biology
• Molecular Oncology

Background:

• Distinguishing specific genetic changes from general instability during cancer progression is challenging.
• Core-binding factor (CBF) acute myeloid leukemias (AMLs) offer a model due to their relatively simple initial karyotypes.

Purpose of the Study:

• To investigate the selection of specific chromosomal changes during tumor progression in two distinct CBF AML subtypes.
• To correlate cytogenetic alterations with acquired somatic mutations and gene expression profiles.

Main Methods:

• Analysis of karyotypic changes at diagnosis and relapse in 94 inv(16)-AML and 82 t(8;21)-AML cases.
• Comparison of DNA replication/repair gene expression and mutation status (KRAS, NRAS, FLT3, KIT) with cytogenetic data.

Main Results:

• Both AML types showed aneuploid progression with distinct chromosome copy number changes (+22, +13 in inv(16)-AML; -Y, -X in t(8;21)-AML).
• Specific cytogenetic changes correlated with mutations (e.g., +8 with RAS mutations).
• Mitotic spindle kinase alterations were linked to aneuploid progression, especially in t(8;21)-AML.

Conclusions:

• Despite similar initiating genetics, CBF AML subtypes exhibit tumor-specific aneuploidy patterns that persist and accumulate.
• Genetic instability, possibly via mitotic spindle dysregulation, rapidly selects for advantageous aneuploidies.